Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2025-12-30 @ 6:15 PM
Study NCT ID:
NCT04315233
Status:
RECRUITING
Last Update Posted:
2025-04-22
First Post:
2020-03-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics
Sponsor:
University of Utah
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-03
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-08
Completion Date Type:
ESTIMATED
First Submit Date:
2020-03-17
First Submit QC Date:
None
Study First Post Date:
2020-03-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-16
Last Update Post Date:
2025-04-22
Last Update Post Date Type:
ACTUAL